# Citalopram for Reflux Hypersensitivity and Functional Heartburn

> **NCT03499171** · PHASE4 · UNKNOWN · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 100 (estimated)

## Conditions studied

- GERD

## Interventions

- **DRUG:** Citalopram 20mg
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03499171
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-27
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499171, "Citalopram for Reflux Hypersensitivity and Functional Heartburn". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03499171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*